Call for Abstracts closes – 10 January 2022 Extended till 1 February 2022
Call for Oral Presentations abstracts CLOSED
Call for Poster Presentations abstracts CLOSED
Results about Oral Presentations distributed after 15 February 2022

All abstracts should contain a title, full names and workplace of the author(s), city, country and email address. Text of the abstract, including the title, should not exceed 3 000 characters without spaces. Submissions must be in English. Do not use commercial drug names. The names of drugs should be referred to by the active substance.

Abstract structure: 
- Introduction 
- Aims and Objectives
- Materials and Methods
- Results
- Conclusions

Use standard abbreviations where appropriate, any unusual abbreviation should be presented in brackets after the full term as used for the first time in the text. All abstracts will be reviewed. 

Accepted abstracts will be selected for Oral presentation or Poster presentation and published in the Congress Online Abstract Book with ISBN code. 


- In order to submit (any number of submissions) you will need to set yourself up as a New User and provide your contact information
- Select “Submit Abstract” to add your submission(s) to the system. The system will prompt you for the required information
- You will be asked for your preference of presentation format – either oral or poster
- Please submit abstracts only in Microsoft Word (.docx) version


- The online system will enable you to add multiple submissions to your profile
- All submissions will be acknowledged by E-mail. If you have not had a confirmation of receipt within 5 working days of your submission, please contact the Congress Secretariat
- Reviewers will review all abstracts and their decision on the acceptability of the abstract and format of the presentation will be final. No correspondence on their decision can be initiated by the author(s)
- Please note that final enrolment of the Abstract in the programme will require the presenting author of abstract to be registered at the Congress.
- Instructions on the duration of oral presentations and the format of posters, will be given in the result correspondence which is planned for issue after 15 February 2022. This includes the confirmation of acceptance or decline